According to two new studies presented Thursday at the San Antonio Breast Cancer Symposium, active monitoring of ductal ...

Researchers examined pooled data from two clinical trials that enrolled patients with low- or intermediate-grade ductal ...

B reast cancer is not a single disease but multiple ones, each carrying varying degrees of risk for endangering women’s ...

The first study comparing surgery to active monitoring as treatment for ductal carcinoma in situ (DCIS) finds women who carefully monitor the precancerous cells are no more likely to develop breast ...

Patients with low-risk ductal carcinoma in situ (DCIS) who underwent active monitoring reported comparable physical, ...

Some early breast cancer patients can safely avoid certain surgeries. That's according to two studies published Thursday that ...

An analysis of phase 3 trials found tamoxifen significantly reduced 15-year ipsilateral breast recurrence in patients with ...

Active monitoring for low-risk ductal carcinoma in situ (DCIS) did not lead to a higher rate of ipsilateral invasive cancer ...

Women report having similar quality of life whether randomized to active monitoring or surgery for low-risk ductal carcinoma ...

Patients with low-risk ductal carcinoma in situ (DCIS) who underwent active monitoring reported comparable physical, emotional, and psychological outcomes to patients who received upfront treatment, ...

Ductal carcinoma in situ, or DCIS, accounts for up to 25% of diagnosed breast cancers and affects more than 50,000 women each year, according to the American Cancer Society. Often called “stage-zero ...

Two recent studies explore options for early-stage breast cancer patients to reduce surgery. One suggests active monitoring ...